Stay updated on TAK-861 in Narcolepsy Type 1 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.

Latest updates to the TAK-861 in Narcolepsy Type 1 Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded the 2026 JAMA Neurology citation for Oveporexton and removed the 2025 ahead-of-print citation for the same article.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a site revision note (Revision: v3.4.2) and removed an older funding-status notice; no study-specific content, eligibility criteria, or results were changed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding lapse and updated operating status guidance, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. No substantive study data, criteria, outcomes, contacts, or locations were changed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to TAK-861 in Narcolepsy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.